AWE
IBB icon

Avidian Wealth Enterprises’s iShares Biotechnology ETF IBB Stock Holding History

Avidian Wealth Enterprises’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$383K Sell
2,015
-133
-6% -$22.9K 0.01% 536
2026
Q1 		$363K Hold
2,148
– – 0.01% 504
2025
Q4 		$362K Buy
2,148
+36
+2% +$5.85K 0.01% 437
2025
Q3 		$305K Hold
2,112
– – 0.01% 468
2025
Q2 		$267K Sell
2,112
-384
-15% -$47.1K 0.01% 462
2025
Q1 		$319K Sell
2,496
-2
-0.1% -$271 0.01% 404
2024
Q4 		$330K Hold
2,498
– – 0.01% 381
2024
Q3 		$364K Buy
2,498
+300
+14% +$43.4K 0.02% 358
2024
Q2 		$302K Sell
2,198
-78
-3% -$10.4K 0.01% 390
2024
Q1 		$312K Buy
2,276
+50
+2% +$6.83K 0.02% 351
2023
Q4 		$302K Buy
+2,226
New +$272K 0.02% 338
2023
Q3 		– Sell
-1,929
Closed -$245K – 410
2023
Q2 		$245K Buy
1,929
+15
+0.8% +$1.95K 0.02% 369
2023
Q1 		$247K Buy
1,914
+16
+0.8% +$2.09K 0.01% 419
2022
Q4 		$249K Buy
1,898
+1
+0.1% +$129 0.02% 393
2022
Q3 		$222K Hold
1,897
– – 0.02% 374
2022
Q2 		$223K Buy
1,897
+210
+12% +$24.9K 0.02% 401
2022
Q1 		$220K Hold
1,687
– – 0.01% 443
2021
Q4 		$258K Buy
+1,687
New +$261K 0.02% 441
2019
Q3 		– Sell
-1,868
Closed -$204K – 200
2019
Q2 		$204K Sell
1,868
-133,636
-99% -$14.2M 0.05% 138
2019
Q1 		$15.1M Buy
135,504
+41,330
+44% +$4.53M 3.37% 9
2018
Q4 		$9.08M Sell
94,174
-10,324
-10% -$1.1M 3.17% 12
2018
Q3 		$12.7M Sell
104,498
-2,613
-2% -$308K 3.99% 8
2018
Q2 		$11.8M Buy
107,111
+1,047
+1% +$112K 3.71% 10
2018
Q1 		$11.3M Buy
106,064
+6,315
+6% +$700K 3.79% 12
2017
Q4 		$10.7M Buy
+99,749
New +$10.7M 2.85% 13

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $22.8B AUM 28.56% 1-Year Est. Return

Avidian Wealth Enterprises's IBB Position: Q2 2026 in Review

Avidian Wealth Enterprises reduced its iShares Biotechnology ETF (IBB) stake by 6.2% in Q2 2026, selling an estimated $22.9K and leaving 2,015 shares worth $383K. The position accounts for 0.01% of the portfolio, ranked #536.

Avidian Wealth Enterprises first reported a position in IBB in Q4 2017 and has held it in 25 quarters since. The position peaked at $15.1M in Q1 2019. 956 funds tracked by Wall St. Rank hold IBB as of Q2 2026.

  • Avidian Wealth Enterprises held 2,015 shares of iShares Biotechnology ETF worth $383K as of Q2 2026.
  • Avidian Wealth Enterprises sold 133 iShares Biotechnology ETF shares in Q2 2026, an estimated $22.9K.
  • iShares Biotechnology ETF made up 0.01% of Avidian Wealth Enterprises's portfolio in Q2 2026, its #536 holding.
  • Avidian Wealth Enterprises first reported a position in iShares Biotechnology ETF in Q4 2017 and has held it in 25 quarters since.
  • Avidian Wealth Enterprises's iShares Biotechnology ETF position peaked at $15.1M in Q1 2019.
  • 956 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q2 2026.

Based on Avidian Wealth Enterprises's 13F filing for Q2 2026, filed 24 Jul 2026.